# A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults

> **NCT06670170** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PF-07976016 Formulation A
- **DRUG:** PF-07976016 Formulation B

## Key facts

- **NCT ID:** NCT06670170
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-05
- **Primary completion:** 2024-12-24
- **Final completion:** 2025-01-17
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06670170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06670170, "A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06670170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*